Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03104842
Title Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Universitatsklinikum Hamburg-Eppendorf
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Vivantes Am Urban Berlin 10967 Germany Details
Campus Benjamin Franklin Charite Berlin Berlin Germany Details
Vivantes Klinikum Neukölln Berlin Germany Details
Städt. Kliniken Bielefeld Klinikum Mitte Bielefeld Germany Details
Johanniter-Krankenhaus Bonn Bonn 53113 Germany Details
Uniklinikum Chemnitz Chemnitz Germany Details
St. Antonius Hospital Eschweiler Germany Details
Universitätsklinikum Essen Essen Germany Details
Asklepios Altona Hamburg Germany Details
University Hospital Hamburg Eppendorf Hamburg Germany Details
University Hospital Heidelberg Heidelberg Germany Details
Uniklinik Köln Koln Germany Details
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz D-55131 Germany Details
Philipps-Universität Marburg Marburg 35032 Germany Details
Kliniken Maria Hilf GmbH, Klinik für Hämatologie, Onkologie und Gastroenterologie Mönchengladbach 41063 Germany Details
Klinikum Osnabrück Osnabrück Germany Details
Universitätsklinikum Tuebingen Tuebingen Germany Details
*Shaded cells indicate that there was no data available from for the field